Drug Information and Journal Club - Longitudinal
Preceptor: Amanda Keith, Pharm.D., BCPS
Interpreting and providing drug information is an integral part of pharmacy practice. Throughout the residency year there will be opportunities to respond to drug information requests from practitioners and staff members. These requests provide the opportunity for each resident to apply clinical and outcomes research concepts to professional practice. Practitioner requests for information also help to develop collaboration between residents and providers, as well as to further develop communication skills. In addition, each pharmacy resident will present at minimum, four formal journal clubs during the residency year (traditionally five each). Residents will attend all journal clubs presented by fellow residents and others as required by rotation preceptors.
Medical Emergencies (code blue) - Longitudinal
Preceptor: Jeff Duncan, Pharm.D., BCCCP
While not official members of the Code Blue Team at Centra Health, clinical pharmacists and residents respond to code blue calls during working hours of 7am-1630. The resident will attend American Heart Association ACLS training in August and will participate in Code Blue pages at Lynchburg General and Virginia Baptist Hospitals throughout the residency year. Residents will respond immediately to Code Blue calls when announced overhead. Activities may include, but are not limited to assisting with CPR, preparing medicated drips and syringes, proper labeling of prepared medications, dose/drip calculations, answering iv compatibility questions, obtaining medications from the main pharmacy, and additional support as needed. The resident will round with the Medical Emergency Team (MET) nurse for one day during the critical care rotation and will attend at least one Centra Resuscitation Committee meeting during the residency year.
Pharmacy & Therapeutics/Medication Safety - Longitudinal
Preceptor: Stephanie Puckett, Pharm.D., BCPS
The Pharmacy & Therapeutics Committee at Centra Health consists of physicians, pharmacists, medical and nursing executives. The committee meets five times per year. Items discussed at P&T are new formulary items, adverse drug event monitoring, therapeutic substitution, order set development, and therapeutic class reviews. During this longitudinal experience, the resident will attend all P&T meetings. The resident will review the literature, prepare and present drug monographs and reviews when needed. The resident will participate in a medication use evaluation during the residency year.
Residents will also take part in retrospective ADE reviews. Various other meetings including Medication Safety Committee meeting. Error reporting and adverse event related monitoring projects may be assigned as necessary throughout this longitudinal rotation, including root cause analysis participation.
Residency Project - Longitudinal
Preceptor: Stephanie Puckett, Pharm.D., BCPS
A project administered by the resident and mentored by a primary preceptor is required of all residents. The project is to be of benefit to the individual, the department, and to the institution. There is to be a significant amount of literature review, project design, data collection, statistical evaluation, writing, and reporting done by the resident. A poster describing interim results or final results will be presented at ASHP Midyear Clinical Meeting. The final product will be presented at the Eastern States Residency Conference and to Centra staff. A written manuscript suitable for publication in a selected journal is required.